However, these genes are rarely altered in human cancer and are dispensable for tumor suppression in most model systems [13,14], suggesting that other components of the p53 tumor-suppressive pathway are central to the tumor suppressor phenotype and targeted for alteration in tumorigenesis. The gene discussed is TP53; the disease is cancer.